Apple

India’s manufacturing sector faces significant challenges as Pfizer and Apple encounter production issues. Pfizer suspended the sale of four antibiotics due to manufacturing deviations at a contractor plant. Apple struggles with weak infrastructure, logistics, and low yield in its manufacturing operations. India’s lack of robust infrastructure, shortage of skilled labor, complex regulations, and bureaucratic hurdles contribute to the difficulties faced by multinational companies. Despite attempts to attract foreign investment, many firms have opted to leave India.